Skip to content
Study details
Enrolling now

Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction

Ayal A. Aizer, MD
NCT IDNCT07132190ClinicalTrials.gov data as of Apr 2026
Phase

Phase 2

Target enrollment

60

Study length

about 4 years

Ages

18+

Locations

1 site in MA

What this study is about

This trial is testing a new way to treat brain metastases. It involves planning and delivering radiation on the same day, aiming to keep the tumors within the treatment area. The goal is to see if this approach is feasible and effective.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Receive Linear accelerator-based stereotactic radiation for brain metastases using 0mm or 1mm PTV

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized & Blinded

You may get a placebo/standard care, and you won't know which.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Secondary: Neurocogntive function via Mini Mental Status Examination (MMSE), Overall survival, Performance status, Progression free survival, Quality of life/symptom burden and interference

Procedures

radiation

Body systems

Neurology, Oncology